#news #biotech Abingworth, Gimv and Pfizer back stealthy Swiss startup’s $61M round to crack gene therapy delivery

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Abingworth, Gimv and Pfizer back stealthy Swiss startup’s $61M round to crack gene therapy delivery .Abingworth, Gimv and Pfizer back stealthy Swiss startup’s $61M round to crack gene therapy delivery
ntaylor
Wed, 09/15/2021 – 09:17

from FierceBiotech: Biotech https://ift.tt/2XkMuP0